MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,765.36
-0.47%
NASDAQ 100
$30,725.81
-1.39%
DOW JONES
$51,232.00
+0.10%
NASDAQ Composite
$27,193.34
-1.25%
RUSSELL 2000
$2,775.70
-0.05%
CBOE VIX
$15.41
+2.19%
Sector Heatmap
Technology-1.79%
Financials+0.89%
Healthcare-0.39%
Consumer Cycl+0.31%
Consumer Staples+2.11%
Energy+2.97%
Industrials+0.33%
Materials+0.59%
Real Estate+0.69%
Utilities-0.19%
Comm Services+0.73%
SCYX — SCYNEXIS, Inc.
NasdaqSCYNEXIS, Inc.
$4.22
-0.56(-11.72%)
- O
- 4.70
- H
- 4.75
- L
- 4.11
- V
- 343.88K
⏱️ End-of-day dataAs of Oct 8, 2026
SCYX — Latest News & Headlines
7 StoriesA U.S. health agency could provide up to about $214 million to develop an antifungal treatment if all options are exercised. - Stock Titan
A U.S. health agency could provide up to about $214 million to develop an antifungal treatment if all options are exercised. Stock Titan
SCYX Stock Draws Trader Focus As New CFO And ADPKD Pivot Take Shape - Timothy Sykes
SCYX Stock Draws Trader Focus As New CFO And ADPKD Pivot Take Shape Timothy Sykes
Scynexis stock surges on $214M BARDA contract for SCY-247 - Yahoo Finance
Scynexis stock surges on $214M BARDA contract for SCY-247 Yahoo Finance
SCYNEXIS (SCYX) Completes Phase 1 Trial for SCY-770 Targeting AD - GuruFocus
SCYNEXIS (SCYX) Completes Phase 1 Trial for SCY-770 Targeting AD GuruFocus
SCYNEXIS Inc. (SCYX) Edges Up 0.87% to $4.66 as Shares Hold Above Key Support - Gamma Flip Level - https://www.siam.in/
SCYNEXIS Inc. (SCYX) Edges Up 0.87% to $4.66 as Shares Hold Above Key Support - Gamma Flip Level https://www.siam.in/
Scynexis Shares Rise 13.9% After BARDA Awards SCY-247 Development Contract - Yahoo Finance
Scynexis Shares Rise 13.9% After BARDA Awards SCY-247 Development Contract Yahoo Finance
SCYNEXIS Secures BARDA Funding for Antifungal Pipeline - TipRanks
SCYNEXIS Secures BARDA Funding for Antifungal Pipeline TipRanks